Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19
Harmony R. Reynolds(Anna Needs Neuroblastoma Answers), Judith S. Hochman(New York University), Samrachana Adhikari(New York University), Anaïs Hausvater(New York University), Stephen B. Johnson(New York University), Jonathan Newman(New York University), Glenn I. Fishman(New York University), Sripal Bangalore(New York University), Gbenga Ogedegbe(Institute for Family Health), Stuart D. Katz(Andover Eye Associates), Claudia Pulgarin(New York University), Eduardo Iturrate(NYU Langone Health), Jeffrey S. Berger(New York University), Dennis Kunichoff(Physicians for Human Rights), Yu Chen(New York University), Andrea B. Troxel(Andover Eye Associates)
Cited by 1,115
Related Papers
American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy
|Journal of the American College of Cardiology|2003|1.6k
European Society of Hypertension Position Paper on Ambulatory Blood Pressure Monitoring
|Journal of Hypertension|2013|1.4k
European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring
|Journal of Hypertension|2014|1k
ST-Segment Elevation in Patients with Covid-19 — A Case Series
|New England Journal of Medicine|2020|858
Self-report measures of medication adherence behavior: recommendations on optimal use
|Translational Behavioral Medicine|2015|832